Open Offers
A selection of Tax Efficient Opportunities open for investment. Delve in deeper and read Hardman research reports and take a few minutes to watch our videos to get a better insight on the people, the funds, and their difference.
Ascension Life Fund
The Ascension Life Fund is a specialist early-stage EIS fund focussing on the UK HealthTech and Life Sciences sectors. Since launching in January, the Life Fund has made five investments with another Term Sheet agreed. These investments include Novai (a retinal...
Deepbridge Life Sciences EIS
The Deepbridge Life Sciences EIS is an opportunity to participate in a portfolio of actively-managed growth focused life sciences companies, taking advantage of the potential tax benefits available under the Enterprise Investment Scheme. A diversified portfolio of...
Downing FOUR Healthcare VCT
Downing FOUR Ventures VCT
Downing Healthcare Knowledge Intensive EIS
Downing Ventures EIS
Mercia Knowledge Intensive Impact EIS fund
Our approved (knowledge-intensive) fund provides full EIS deployment in the 2021/2022 tax year, and will invest in companies that target the UN’s Sustainable Development Goals. We aim to deliver Mercia’s same tripling target as our main EIS fund, but with additional...
Oskare Capital UK
Oxford Technology Combined SEIS and EIS Fund – “The Start-up Fund”
Oxford Technology invests in high-risk, high-reward technology start-ups, in general within an hour’s drive of Oxford, and has been doing this since 1983. The latest fund, OT(S)EIS, made its first investment in late 2012. By the end of 2021, OT(S)EIS had completed 177...
Regenerate Ventures
The Climate Positive Agriculture Fund from Regenerate Ventures is tackling the twin imperatives of reducing climate change and making agriculture more efficient. Without dramatic changes in both of these, the outlook for our planet looks bleak. After all, the...
The o2h human health EIS knowledge intensive fund
The o2h human health EIS fund is our flag-ship fund and was the first HMRC approved Knowledge-intensive fund that will invest in EIS qualifying knowledge-intensive companies. The o2h human health funds invest in early stage biotech therapeutic companies focused on...